VNBTrust National Association’s Teva Pharmaceuticals TEVA Stock Holding History

VNBTrust National Association’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,615	Closed	-$237K	–	140
2015 Q4	$237K	Hold	3,615	–	–	0.13%	125
2015 Q3	$204K	Sell	3,615 -220	-6%	-$14.3K	0.12%	135
2015 Q2	$227K	Sell	3,835 -295	-7%	-$18.2K	0.11%	136
2015 Q1	$257K	Sell	4,130 -1,000	-19%	-$58.1K	0.12%	128
2014 Q4	$295K	Buy	5,130 +150	+3%	+$8.36K	0.13%	124
2014 Q3	$268K	Hold	4,980	–	–	0.14%	106
2014 Q2	$261K	Sell	4,980 -45	-0.9%	-$2.3K	0.13%	112
2014 Q1	$266K	Hold	5,025	–	–	0.13%	107
2013 Q4	$201K	Buy	+5,025	New	+$198K	0.1%	134

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VNBTrust National Association's TEVA Position: Q1 2016 in Review

VNBTrust National Association sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,615 shares — an estimated $237K sold.

VNBTrust National Association first reported a position in TEVA in Q4 2013 and held it in 9 quarters. The position peaked at $295K in Q4 2014. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

VNBTrust National Association reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
VNBTrust National Association sold 3,615 Teva Pharmaceuticals shares in Q1 2016, an estimated $237K.
VNBTrust National Association first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 9 quarters.
VNBTrust National Association's Teva Pharmaceuticals position peaked at $295K in Q4 2014.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on VNBTrust National Association's 13F filing for Q1 2016, filed 28 Apr 2016.